4,692
Views
38
CrossRef citations to date
0
Altmetric
Review

CEACAM1 as a multi-purpose target for cancer immunotherapy

ORCID Icon, ORCID Icon, , ORCID Icon & ORCID Icon
Article: e1328336 | Received 17 Feb 2017, Accepted 05 May 2017, Published online: 28 Jun 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Aditya Gupta, Andrew J. Rosato & Feng Cui. (2021) Vaccine candidate designed against carcinoembryonic antigen-related cell adhesion molecules using immunoinformatics tools. Journal of Biomolecular Structure and Dynamics 39:16, pages 6084-6098.
Read now
Reem Saleh, Salman M Toor & Eyad Elkord. (2020) Targeting TIM-3 in solid tumors: innovations in the preclinical and translational realm and therapeutic potential. Expert Opinion on Therapeutic Targets 24:12, pages 1251-1262.
Read now
Philip M. Arlen & Maria Pia Morelli. (2020) Rationale, discovery and clinical development of NEO-201. Expert Opinion on Biological Therapy 20:2, pages 105-108.
Read now
Estefania Carrasco-Garcia, María Álvarez-Satta, Mikel García-Puga, Marcelo Lima Ribeiro, Sara Arevalo, Marcos Arauzo-Bravo & Ander Matheu. (2019) Therapeutic relevance of SOX9 stem cell factor in gastric cancer. Expert Opinion on Therapeutic Targets 23:2, pages 143-152.
Read now

Articles from other publishers (34)

Lisa Götz, Uwe Rueckschloss, Gözde Balk, Verena Pfeiffer, Süleyman Ergün & Florian Kleefeldt. (2023) The role of carcinoembryonic antigen-related cell adhesion molecule 1 in cancer. Frontiers in Immunology 14.
Crossref
Sai Ma, Zhonghua Wang, Chao Li, Zhenli Liu, Xuan Zhang, Liheng Li, Feng An & Xiaoli Qiao. (2023) CEACAM1 as a molecular target in oral cancer. Aging 15:16, pages 8137-8154.
Crossref
Chandrakumar Subramanian, Saurav Panicker & Satish Ramalingam. 2023. Cancer Genes: Volume 2. Cancer Genes: Volume 2 227 250 .
Takanori Kitamura. (2023) Tumour-associated macrophages as a potential target to improve natural killer cell-based immunotherapies. Essays in Biochemistry.
Crossref
Ahmet ACAR. (2023) Integrative profiling of CEACAM1 in different malignancies with implications on the SARS-CoV-2 infection genes ACE2 and TMPRSS2. Hacettepe Journal of Biology and Chemistry 51:2, pages 215-225.
Crossref
Shirong Tan. (2023) Cancer Immunotherapy: A Brief History, The Latest Development of Typical Subtypes and Therapy Combination. Highlights in Science, Engineering and Technology 30, pages 34-43.
Crossref
Jerin Thomas, Addison Klebanov, Sahara John, Larry S. Miller, Anil Vegesna, Richard L. Amdur, Krishanu Bhowmick & Lopa Mishra. (2023) CEACAMS 1, 5, and 6 in disease and cancer: interactions with pathogens. Genes & Cancer 14, pages 12-29.
Crossref
Anthony Lozano, Francois-Régis Souche, Carine Chavey, Valérie Dardalhon, Christel Ramirez, Serena Vegna, Guillaume Desandre, Anaïs Riviere, Amal Zine El Aabidine, Philippe Fort, Leila Akkari, Urszula Hibner & Damien Grégoire. (2023) Ras/MAPK signalling intensity defines subclonal fitness in a mouse model of hepatocellular carcinoma. eLife 12.
Crossref
Anna Kuzevanova, Natalya Apanovich, Danzan Mansorunov, Alexandra Korotaeva & Alexander Karpukhin. (2022) The Features of Checkpoint Receptor—Ligand Interaction in Cancer and the Therapeutic Effectiveness of Their Inhibition. Biomedicines 10:9, pages 2081.
Crossref
Amirreza Khalaji, Sara Haddad, Yalda Yazdani, Mohammadreza Moslemi, Leila Alizadeh & Behzad Baradaran. (2022) A bioinformatics-based study on the Cisplatin-resistant lung cancer cells; what are the orchestrators of this phenom?. Gene 834, pages 146668.
Crossref
Kwong yok Tsang, Massimo Fantini, Sharon A. Mavroukakis, Anjum Zaki, Christina M. Annunziata & Philip M. Arlen. (2022) Development and Characterization of an Anti-Cancer Monoclonal Antibody for Treatment of Human Carcinomas. Cancers 14:13, pages 3037.
Crossref
Muhammad H. Shahzad, Lixuan Feng, Xin Su, Ariane Brassard, Iqraa Dhoparee-Doomah, Lorenzo E. Ferri, Jonathan D. Spicer & Jonathan J. Cools-Lartigue. (2022) Neutrophil Extracellular Traps in Cancer Therapy Resistance. Cancers 14:5, pages 1359.
Crossref
Danzan Mansorunov, Natalya Apanovich, Pavel Apanovich, Fatimat Kipkeeva, Tatyana Muzaffarova, Anna Kuzevanova, Maxim Nikulin, Olga Malikhova & Alexander Karpukhin. (2021) Expression of Immune Checkpoints in Malignant Tumors: Therapy Targets and Biomarkers for the Gastric Cancer Prognosis. Diagnostics 11:12, pages 2370.
Crossref
Jeffrey R. Whiteaker, Rachel A. Lundeen, Lei Zhao, Regine M. Schoenherr, Aura Burian, Dongqing Huang, Ulianna Voytovich, Tao Wang, Jacob J. Kennedy, Richard G. Ivey, Chenwei Lin, Oscar D. Murillo, Travis D. Lorentzen, Mathangi Thiagarajan, Simona Colantonio, Tessa W. Caceres, Rhonda R. Roberts, Joseph G. Knotts, Joshua J. Reading, Jan A. Kaczmarczyk, Christopher W. Richardson, Sandra S. Garcia-Buntley, William Bocik, Stephen M. Hewitt, Karen E. Murray, Nhan Do, Mary Brophy, Stephen W. Wilz, Hongbo Yu, Samuel Ajjarapu, Emily Boja, Tara Hiltke, Henry Rodriguez & Amanda G. Paulovich. (2021) Targeted Mass Spectrometry Enables Multiplexed Quantification of Immunomodulatory Proteins in Clinical Biospecimens. Frontiers in Immunology 12.
Crossref
Liang Wu, Yuxuan Wang, Xiaoyan Wang, Jun Liao, Hao Dong, Xiyunyi Cai, Yurong Wang & Harvest F. Gu. (2021) Evaluation of Colocasia esculenta Schott in anti-cancerous properties with proximity extension assays. Food & Nutrition Research 65.
Crossref
Tian Tian & Zhaoming Li. (2021) Targeting Tim-3 in Cancer With Resistance to PD-1/PD-L1 Blockade. Frontiers in Oncology 11.
Crossref
Amjad Shhadeh, Johanna Galaski, Tamar Alon-Maimon, Jamal Fahoum, Reuven Wiener, Daniel J. Slade, Ofer Mandelboim & Gilad Bachrach. (2021) CEACAM1 Activation by CbpF-Expressing E. coli. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Robert S O'Neill & Alina Stoita. (2021) Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket?. World Journal of Gastroenterology 27:26, pages 4045-4087.
Crossref
I-Tsu Chyuan, Ching-Liang Chu & Ping-Ning Hsu. (2021) Targeting the Tumor Microenvironment for Improving Therapeutic Effectiveness in Cancer Immunotherapy: Focusing on Immune Checkpoint Inhibitors and Combination Therapies. Cancers 13:6, pages 1188.
Crossref
Sansana Sawasdikosol & Steven Burakoff. (2020) A perspective on HPK1 as a novel immuno-oncology drug target. eLife 9.
Crossref
Alba Rodriguez-Garcia, Asis Palazon, Estela Noguera-Ortega, Daniel J. PowellJr.Jr. & Sonia Guedan. (2020) CAR-T Cells Hit the Tumor Microenvironment: Strategies to Overcome Tumor Escape. Frontiers in Immunology 11.
Crossref
Racquel Domingo-Gonzalez, Fabio Zanini, Xibing Che, Min Liu, Robert C Jones, Michael A Swift, Stephen R Quake, David N Cornfield & Cristina M Alvira. (2020) Diverse homeostatic and immunomodulatory roles of immune cells in the developing mouse lung at single cell resolution. eLife 9.
Crossref
Roni F. Rayes, Phil Vourtzoumis, Marianne Bou Rjeily, Rashmi Seth, France Bourdeau, Betty Giannias, Julie Berube, Yu-Hwa Huang, Simon Rousseau, Sophie Camilleri-Broet, Richard S. Blumberg, Nicole Beauchemin, Sara Najmeh, Jonathan Cools-Lartigue, Jonathan D. Spicer & Lorenzo E. Ferri. (2020) Neutrophil Extracellular Trap–Associated CEACAM1 as a Putative Therapeutic Target to Prevent Metastatic Progression of Colon Carcinoma. The Journal of Immunology 204:8, pages 2285-2294.
Crossref
Chun-Yue Weng, Xin-Yi Hu & Ya-Jun Wang. (2020) Integrated analysis of gene expression, alteration and clinical significance of carcinoembryonic antigen-related cell adhesion molecule 1 in cancer. 3 Biotech 10:3.
Crossref
Ritu Pandey, Muhan Zhou, Shariful Islam, Baowei Chen, Natalie K Barker, Paul Langlais, Anup Srivastava, Moulun Luo, Laurence S. Cooke, Eric Weterings & Daruka Mahadevan. (2019) Carcinoembryonic antigen cell adhesion molecule 6 (CEACAM6) in Pancreatic Ductal Adenocarcinoma (PDA): An integrative analysis of a novel therapeutic target. Scientific Reports 9:1.
Crossref
Esther Klaile, Mario M. Müller, Cristina Zubiría-Barrera, Saskia Brehme, Tilman E. Klassert, Magdalena Stock, Adrian Durotin, Tien D. Nguyen, Sabina Feer, Bernhard B. Singer, Peter F. Zipfel, Sven Rudolphi, Ilse D. Jacobsen & Hortense Slevogt. (2019) Unaltered Fungal Burden and Lethality in Human CEACAM1-Transgenic Mice During Candida albicans Dissemination and Systemic Infection. Frontiers in Microbiology 10.
Crossref
Peng Liao, Haofan Wang, Ya-ling Tang, Ya-Jie Tang & Xin-hua Liang. (2019) The Common Costimulatory and Coinhibitory Signaling Molecules in Head and Neck Squamous Cell Carcinoma. Frontiers in Immunology 10.
Crossref
Jason Kuhn, Asya Smirnov, Alison K. Criss & Linda Columbus. (2019) Quantifying Carcinoembryonic Antigen-like Cell Adhesion Molecule-Targeted Liposome Delivery Using Imaging Flow Cytometry. Molecular Pharmaceutics 16:6, pages 2354-2363.
Crossref
Alexandra Soler, Laure Cayrefourcq, Thibault Mazard, Anna Babayan, Pierre-Jean Lamy, Said Assou, Eric Assenat, Klaus Pantel & Catherine Alix-Panabières. (2018) Autologous cell lines from circulating colon cancer cells captured from sequential liquid biopsies as model to study therapy-driven tumor changes. Scientific Reports 8:1.
Crossref
Andreea Calinescu, Gabriela Turcu, Roxana I. Nedelcu, Alice Brinzea, Anastasia Hodorogea, Mihaela Antohe, Carmen Diaconu, Coralia Bleotu, Daniel Pirici, Lucia B. Jilaveanu, Daniela A. Ion & Ioana A. Badarau. (2018) On the Dual Role of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 (CEACAM1) in Human Malignancies. Journal of Immunology Research 2018, pages 1-8.
Crossref
Andrea Horst, Sonia Najjar, Christoph Wagener & Gisa Tiegs. (2018) CEACAM1 in Liver Injury, Metabolic and Immune Regulation. International Journal of Molecular Sciences 19:10, pages 3110.
Crossref
Leticia Oliveira-Ferrer, Roshni Goswami, Vladimir Galatenko, Yi Ding, Kathrin Eylmann, Karen Legler, Sascha Kürti, Barbara Schmalfeldt & Karin Milde-Langosch. (2018) Prognostic Impact of CEACAM1 in Node-Negative Ovarian Cancer Patients. Disease Markers 2018, pages 1-10.
Crossref
Shuhei Hosomi, Joep Grootjans, Yu-Hwa Huang, Arthur Kaser & Richard S. Blumberg. (2018) New Insights Into the Regulation of Natural-Killer Group 2 Member D (NKG2D) and NKG2D-Ligands: Endoplasmic Reticulum Stress and CEA-Related Cell Adhesion Molecule 1. Frontiers in Immunology 9.
Crossref
Robert Torphy, Richard Schulick & Yuwen Zhu. (2017) Newly Emerging Immune Checkpoints: Promises for Future Cancer Therapy. International Journal of Molecular Sciences 18:12, pages 2642.
Crossref